Peter Kolkhof

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

George L. Bakris, Rajiv Agarwal, Stefan D. Anker et al. · New England Journal of Medicine · 2020 · 2.6K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt et al. · European Heart Journal · 2021 · 1.2K citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan et al. · New England Journal of Medicine · 2024 · 709 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

George L. Bakris, Rajiv Agarwal, Juliana C.N. Chan et al. · JAMA · 2015 · 688 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

Bertram Pitt, Piotr Ponikowski, Mihai Gheorghiade et al. · European Heart Journal · 2013 · 575 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14